TL;DR
Glutathione is one of the body's main intracellular antioxidants, not a fringe research chemical. Its basic biology and role in oxidative stress are well established, but evidence for supplements or cosmetic use depends heavily on the route and outcome being studied. NAC has a recognised clinical role in paracetamol overdose because it helps restore glutathione. Skin-lightening and general-wellness claims have a smaller, mixed evidence base and should not be treated as equivalent.
What is Glutathione?
Glutathione is an endogenous tripeptide composed of glutamate, cysteine and glycine (Glu-Cys-Gly), synthesised in essentially all human cells and present in particularly high concentrations in the liver. It is the body's principal intracellular antioxidant, existing in reduced (GSH) and oxidised (GSSG) forms, with the ratio between the two used as a marker of cellular oxidative stress.
Unlike many compounds covered in this library, glutathione has an extensive, decades-deep body of real published research spanning basic biochemistry, clinical nutrition, hepatology and dermatology.
Important distinction: some glutathione uses sit within approved or well-established clinical contexts (for example, intravenous glutathione has been studied and used in specific hospital settings for conditions such as certain forms of liver disease under medical supervision in some jurisdictions), while other uses — most notably cosmetic skin-brightening injections or high-dose oral/IV use for general wellness — are not approved indications; check the exact product's status. This guide treats both contexts factually and keeps them clearly separated. This guide is for educational and research purposes only. Not medical advice.
How strong is the evidence?
| Evidence Type |
Status |
| Human RCT |
✔ |
| Observational |
✔ |
| Animal Studies |
✔ |
| In Vitro |
✔ |
| Regulatory Approval |
Product-specific; this guide does not establish Irish authorisation for a glutathione medicine or a cosmetic IV treatment. |
How does Glutathione work?
Glutathione's central biochemical role is as a redox buffer. The thiol (sulfhydryl) group on its cysteine residue allows reduced glutathione (GSH) to donate electrons to neutralise reactive oxygen species (ROS) and other free radicals, becoming oxidised glutathione (GSSG) in the process. The enzyme glutathione reductase then regenerates GSH from GSSG using NADPH, maintaining the cell's antioxidant capacity in a continuous cycle.
Glutathione is a cofactor for glutathione peroxidase enzymes, which detoxify hydrogen peroxide and lipid peroxides, and for glutathione S-transferase enzymes involved in Phase II liver detoxification. This role underpins the use of its precursor N-acetylcysteine (NAC) in treating paracetamol overdose. Researchers have also examined glutathione's role in melanin synthesis as a possible basis for cosmetic skin-brightening claims. Evidence for cosmetic efficacy and long-term safety is much weaker than the evidence for its core antioxidant and detoxification roles.
What has Glutathione been studied for?
Oxidative Stress and Antioxidant Status
Extensive research has measured glutathione status as a biomarker of oxidative stress across numerous disease states, including diabetes, cardiovascular disease, neurodegenerative conditions and ageing. Depleted glutathione levels are consistently associated with increased oxidative damage markers in these conditions.
Liver Detoxification and Hepatoprotection
Glutathione's role in hepatic Phase II detoxification is one of the best-established areas of research. Clinical research supports NAC in acute paracetamol overdose through the glutathione-precursor pathway. Research has also examined glutathione status in non-alcoholic fatty liver disease (NAFLD) and other hepatic conditions.
Skin Brightening and Cosmetic Use (Off-Label Context)
Dermatological research has examined glutathione for skin-lightening effects, generally in the context of melasma or general cosmetic skin tone applications. This is explicitly an off-label, cosmetic use context — not an HPRA/EMA-approved indication — and the evidence base, while present, is smaller and more mixed than for glutathione's core antioxidant/detoxification roles. Safety of repeated high-dose IV use for cosmetic purposes specifically remains debated.
Respiratory and Immune Function Research
Glutathione depletion has been studied in respiratory conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis, where oxidative stress contributes to disease pathology, with inhaled glutathione and NAC studied as potential supportive interventions.
What did the studies actually find?
| Study / Model |
Reported Effect |
| Clinical use in paracetamol overdose (NAC/glutathione precursor pathway) |
Established, well-documented reduction in hepatotoxicity and mortality when administered promptly following overdose; a recognised emergency medicine standard of care. |
| Oral/IV glutathione RCTs in melasma and skin-lightening research |
Some trials report modest reductions in melanin index versus placebo over 8-12 weeks; effect sizes are variable and evidence quality is mixed across studies. |
| NAFLD and liver enzyme studies |
Some studies report improvements in liver enzyme markers (ALT/AST) with glutathione or NAC supplementation, though results are not uniformly consistent across trials. |
| COPD / respiratory oxidative stress studies |
Reduced markers of oxidative stress reported with glutathione or NAC supplementation in some respiratory disease cohorts. |
| Ageing and mitochondrial function research |
Cross-sectional studies report declining glutathione synthesis capacity with age, associated with increased oxidative damage markers. |
Sport and IV administration: Under M2.2 of the WADA 2026 Prohibited List, IV infusions or injections totalling more than 100 mL in a 12-hour period are prohibited at all times, except when legitimately received during hospital treatment, surgery or clinical diagnostic investigations. This method restriction applies regardless of whether the substance itself is prohibited.
What side effects were reported?
- Abdominal bloating and cramping (oral use)
- Mild allergic-type reactions, including skin rash (more frequently reported with IV administration)
- Rare reports of Stevens-Johnson syndrome-type reactions associated with unsupervised high-dose IV glutathione injections outside clinical settings
- Theoretical concern regarding long-term high-dose cosmetic IV use altering normal pigmentation regulation, though long-term safety data specifically for cosmetic dosing regimens is limited
Clinical research generally reports good tolerance at standard oral doses. Higher-dose IV cosmetic use has much less long-term safety evidence and requires medical supervision.
Glutathione at a glance
- CAS Number
- 70-18-8
- Molecular Formula
- C10H17N3O6S
- Molecular Weight
- 307.32 g/mol
- Half-Life
- Plasma half-life of exogenous glutathione is short (minutes), as it is rapidly broken down by gamma-glutamyl transferase; intracellular glutathione turnover operates on a separate, longer synthesis/regeneration cycle
- Synonyms
- GSH, L-Glutathione, Reduced Glutathione, Gamma-glutamylcysteinylglycine
- Research Classification
- Endogenous tripeptide, principal intracellular antioxidant; medicine authorisation must be checked for the exact product and indication
The research this page cites
- Pizzorno J et al. 2014 — Glutathione!. — Integrative Medicine: A Clinician's Journal — [Review]
- Smilkstein MJ et al. 1988 — Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). — The New England journal of medicine — [Human clinical trial]
- Handog EB et al. 2016 — An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino women. — Journal of Cosmetic Dermatology — [Human RCT, cosmetic/off-label context]
- Sinha R et al. 2018 — Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. — European journal of clinical nutrition — [Research paper]
- Rahman I et al. 2000 — Oxidative stress and regulation of glutathione in lung inflammation. — European Respiratory Journal — [Review, respiratory research]
- Sekhar RV et al. 2011 — Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. — Diabetes Care — [Human RCT]
*This compliance check is automated and does not constitute legal advice. No Nonsense Fitness recommends independent legal review for all published content.*
